Cerebral microbleeds: evidence of heightened risk associated with aspirin use.
Gorelick
Philip B
PB
D001241:Aspirin / Q000009:adverse effects*; D015415:Biomarkers / Q000032:analysis; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002536:Cerebral Arteries / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology* / Q000503:physiopathology; D015331:Cohort Studies; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008279:Magnetic Resonance Imaging; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D018570:Risk Assessment; D012307:Risk Factors
D015415:Biomarkers; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin